Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-10-2012 | Poster presentation

Antimalarial treatment by health care providers in Port Harcourt, Nigeria

Authors: Omotayo O Ebong, Eme O Asuquo, Chijioke A Nwauche, lyeopu M Siminialayi, Ijeoma H Ogbuehi, Mercy F Ajienka

Published in: Malaria Journal | Special Issue 1/2012

Login to get access

Excerpt

In Nigeria, malaria accounts for 60% of outpatient visits, 30% hospitalization, and is estimated to be responsible for about 11% of overall maternal mortality, 25% of infant mortality, and 30% of under-five mortality [1]. The disease is particularly virulent among pregnant women and the under-five years of age, due to their low levels of immunity. It impedes economic growth and keeps households in poverty. Lack of access to diagnostic testing before treatment is one of the weaknesses in the management of malaria in Nigeria [2]. This study examines the treatment practice for malaria among health care providers (HCPs) in Port Harcourt. …
Metadata
Title
Antimalarial treatment by health care providers in Port Harcourt, Nigeria
Authors
Omotayo O Ebong
Eme O Asuquo
Chijioke A Nwauche
lyeopu M Siminialayi
Ijeoma H Ogbuehi
Mercy F Ajienka
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-S1-P28

Other articles of this Special Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine